[1] Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. European heart journal. 2006;27(22):2725-36.
[2] Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46(1):57-64.
[3] Bueno H, Ross JS, Wang Y, Chen J, Vidán MT, Normand SL, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. Jama. 2010;303(21):2141-7.
[4] Fonarow GC, Adams KF, Jr., Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. Jama. 2005;293(5):572-80.
[5] Hollenberg SM, Warner Stevenson L, Ahmad T, Amin VJ, Bozkurt B, Butler J, et al. 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019;74(15):1966-2011.
[6] Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart failure. 2014;2(5):429-36.
[7] Passantino A, Monitillo F, Iacoviello M, Scrutinio D. Predicting mortality in patients with acute heart failure: Role of risk scores. World J Cardiol. 2015;7(12):902-11.
[8] Jentzer JC, van Diepen S, Murphree DH, Ismail AS, Keegan MT, Morrow DA, et al. Admission diagnosis and mortality risk prediction in a contemporary cardiac intensive care unit population. American Heart Journal. 2020;224:57-64.
[9] Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29.
[10] Spinar J, Jarkovsky J, Spinarova L, Mebazaa A, Gayat E, Vitovec J, et al. AHEAD score--Long-term risk classification in acute heart failure. Int J Cardiol. 2016;202:21-6.
[11] Cameli M, Pastore MC, De Carli G, Henein MY, Mandoli GE, Lisi E, et al. ACUTE HF score, a multiparametric prognostic tool for acute heart failure: A real-life study. Int J Cardiol. 2019;296:103-8.
[12] Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2016;37(27):2129-200.
[13] Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology : JASN. 2006;17(10):2937-44.
[14] Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Statistics in Medicine. 2004;23(10):1631-60.
[15] Auble TE, Hsieh M, Gardner W, Cooper GF, Stone RA, McCausland JB, et al. A prediction rule to identify low-risk patients with heart failure. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2005;12(6):514-21.
[16] Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circulation Cardiovascular quality and outcomes. 2010;3(1):25-32.
[17] Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. Jama. 2006;296(18):2217-26.
[18] Al-Lawati JA, Sulaiman KJ, Al-Zakwani I, Alsheikh-Ali AA, Panduranga P, Al-Habib KF, et al. Systolic Blood Pressure on Admission and Mortality in Patients Hospitalized With Acute Heart Failure: Observations From the Gulf Acute Heart Failure Registry. Angiology. 2017;68(7):584-91.
[19] Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends in immunology. 2010;31(8):318-24.
[20] Riad A, Weitmann K, Herda LR, Empen K, Gross S, Nauck M, et al. Initial white blood cell count is an independent risk factor for survival in patients with dilated cardiomyopathy. Int J Cardiol. 2013;168(2):1207-13.
[21] Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39(11):1780-6.
[22] von Haehling S, Schefold JC, Hodoscek LM, Doehner W, Mannaa M, Anker SD, et al. Anaemia is an independent predictor of death in patients hospitalized for acute heart failure. Clinical research in cardiology : official journal of the German Cardiac Society. 2010;99(2):107-13.
[23] Zhang Y, Zhang J, Butler J, Yang X, Xie P, Guo D, et al. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry. J Card Fail. 2017;23(12):868-75.
[24] Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Tang WH, et al. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail. 2016;18(4):424-32.
[25] Málek F, Ošťádal P, Pařenica J, Jarkovský J, Vítovec J, Widimský P, et al. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry. Journal of critical care. 2012;27(6):737.e11-24.
[26] Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Failure Reviews. 2014;19(4):453-70.
[27] Stojcevski B, Celic V, Navarin S, Pencic B, Majstorovic A, Sljivic A, et al. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure. European heart journal Acute cardiovascular care. 2017;6(8):676-84.
[28] Wessler BS, Ruthazer R, Udelson JE, Gheorghiade M, Zannad F, Maggioni A, et al. Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure. Journal of the American Heart Association. 2017;6(11).